Literature DB >> 16421239

A pooled analysis of second primary pancreatic cancer.

Min Shen1, Paolo Boffetta, Jørgen H Olsen, Aage Andersen, Kari Hemminki, Eero Pukkala, Elizabeth Tracey, David H Brewster, Mary L McBride, Vera Pompe-Kirn, Erich V Kliewer, Jon M Tonita, Kee-Seng Chia, Carmen Martos, Jon G Jonasson, Didier Colin, Ghislaine Scélo, Paul Brennan.   

Abstract

Studies of pancreatic cancer in the setting of second primary malignant neoplasms can provide etiologic clues. An international multicenter study was carried out using data from 13 cancer registries with a registration period up to year 2000. Cancer patients were followed up from the initial cancer diagnosis, and the occurrence of second primary malignant neoplasms was compared with expected values derived from local rates, adjusting for age, sex, and period of diagnosis. Results from individual registries were pooled by use of a fixed-effects model. People were at higher risk of developing pancreatic cancer within 10 years of a diagnosis of cancers of the pharynx, stomach, gallbladder, larynx, lung, cervix, corpus uteri, bladder, and eye and 10 years or later following a diagnosis of cancers of the stomach, colon, gallbladder, breast, cervix, placenta, corpus uteri, ovary, testis, bladder, kidney, and eye, as well as Hodgkin's and non-Hodgkin's lymphomas. Pancreatic cancer was connected with smoking-related cancers, confirming the etiologic role of tobacco. The associations with uterine and ovarian cancers suggest that reproductive factors might be implicated in pancreatic carcinogenesis. The elevated pancreatic cancer risk in young patients observed among several types of cancer implies a role of genetic factors. Radiotherapy is also suggested as a risk factor.

Entities:  

Mesh:

Year:  2006        PMID: 16421239     DOI: 10.1093/aje/kwj073

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Outcomes in patients with pancreatic cancer as a secondary malignancy: a retrospective single-institution study.

Authors:  Sojun Hoshimoto; Shoichi Hishinuma; Hirofumi Shirakawa; Moriaki Tomikawa; Iwao Ozawa; Yoshiro Ogata
Journal:  Langenbecks Arch Surg       Date:  2019-11-25       Impact factor: 3.445

2.  Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers.

Authors:  Sunil Amin; Russell B McBride; Jennie K Kline; Elana B Mitchel; Aimee L Lucas; Alfred I Neugut; Harold Frucht
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

3.  Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study.

Authors:  Erik Rahimi; Sachin Batra; Nirav Thosani; Harminder Singh; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

4.  Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Authors:  G M Dores; R E Curtis; F E van Leeuwen; M Stovall; P Hall; C F Lynch; S A Smith; R E Weathers; H H Storm; D C Hodgson; R A Kleinerman; H Joensuu; T B Johannesen; M Andersson; E J Holowaty; M Kaijser; E Pukkala; L Vaalavirta; S D Fossa; F Langmark; L B Travis; J F Fraumeni; B M Aleman; L M Morton; E S Gilbert
Journal:  Ann Oncol       Date:  2014-07-25       Impact factor: 32.976

5.  Development and validation of a competing risk model for second primary pancreatic ductal adenocarcinoma: A population-based study.

Authors:  Lishan Song; Chaojie Xu; Tong Zhang; Shengyang Chen; Zhigang Shi; Shuiquan Hu; Bingbing Cheng; Hao Tong; Guangkun Wei; Xiaoyong Li
Journal:  Front Surg       Date:  2022-08-30

6.  The tobacco carcinogen NNK is stereoselectively reduced by human pancreatic microsomes and cytosols.

Authors:  Neil Trushin; Gerhard Leder; Karam El-Bayoumy; Dietrich Hoffmann; Hans G Beger; Doris Henne-Bruns; Marco Ramadani; Bogdan Prokopczyk
Journal:  Langenbecks Arch Surg       Date:  2008-02-08       Impact factor: 3.445

7.  A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.

Authors:  Hao Liu; Kari Hemminki; Jan Sundquist; Bernd Holleczek; Alexander Katalinic; Katharina Emrich; Lina Jansen; Hermann Brenner
Journal:  Cancer Med       Date:  2013-08-27       Impact factor: 4.452

8.  Familial association of pancreatic cancer with other malignancies in Swedish families.

Authors:  E Hiripi; J Lorenzo Bermejo; X Li; J Sundquist; K Hemminki
Journal:  Br J Cancer       Date:  2009-10-13       Impact factor: 7.640

9.  The impact of a history of cancer on pancreatic ductal adenocarcinoma survival.

Authors:  Xingkang He; Yue Li; Tingting Su; Sanchuan Lai; Wenrui Wu; Luyi Chen; Jianmin Si; Leimin Sun
Journal:  United European Gastroenterol J       Date:  2018-04-30       Impact factor: 4.623

Review 10.  Epidemiology of pancreatic cancer.

Authors:  Milena Ilic; Irena Ilic
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.